Prevalence of Musculoskeletal Pain and Rheumatic Diseases in the Southeastern Region of Mexico. A COPCORD-Based Community Survey

Álvarez-Nemegyei, José; Peláez‐Ballestas, Ingris; Sanı́n, Luz Helena; Cardiel, Mario H.; Ramirez-Angulo, Angelica; Goycochea-Robles, María Victoria

doi:10.3899/jrheum.100954

Cited by 60 publications

(35 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Epidemiologic studies have shown that the frequency of AS and SpA in a given population parallels the frequency of HLA-B27 22-36 (Tables 3-4). In early axial SpA, one recent study has shown that HLA-B27 is associated with earlier onset of IBP, less delay in diagnosis, axial inflammation (spine and sacroiliac joints), radiographic damage of the sacroiliiac joint, decreased disease activity, and lower frequency of psoriasis, but not with physical function and MRI structural lesions of the sacroiliac joints 37 .…”

Section: The Importance Of Hla-b27 In Axspa and Asmentioning

confidence: 99%

The Epidemiology of Back Pain, Axial Spondyloarthritis and HLA-B27 in the United States

Reveille

Weisman

2013

The American Journal of the Medical Sciences

166

105

View full text Add to dashboard Cite

The concept of inflammatory back pain (IBP) evolved in the 1970s, coincident with the discovery of the HLA-B27 association with ankylosing spondylitis (AS), leading to the development of criteria to determine the presence of IBP. The concept of IBP and it relationship with AS and axial spondyloarthritis (AxSpA) has further evolved, and an instrument developed (the Spondylitis Association of America Back Pain Tool), which was further modified and field tested for use in the 2009-2010 National Health and Nutrition Examination Survey (NHANES). This has shown the frequency of chronic back pain to have risen to 19.4%, with nearly one-third having IBP. The prevalence of AxSpA has been defined at 1.0-1.4% and AS at 0.52-0.55%. The national prevalence of HLA-B27 in the U.S. is 6.1%, and intriguing data from NHANES 2009 suggest a decreasing frequency with increasing age. From this arise new questions and a work agenda ahead.

show abstract

Section: The Importance Of Hla-b27 In Axspa and Asmentioning

confidence: 99%

The Epidemiology of Back Pain, Axial Spondyloarthritis and HLA-B27 in the United States

Reveille

Weisman

2013

The American Journal of the Medical Sciences

166

105

View full text Add to dashboard Cite

show abstract

“…Studies from Latin-America and Africa are scarce. A community-based COPCORD door-to-door study in 4059 subjects aged older than 18 years in Mexico, estimated a prevalence of AS of 0.02% [73]. AS is virtually absent in African blacks.…”

Section: Literature Review On Prevalence and Incidence Spamentioning

confidence: 99%

Epidemiology of Spondyloarthritis

Stolwijk

Boonen

Tubergen

et al. 2012

Rheumatic Disease Clinics of North America

204

125

View full text Add to dashboard Cite

Synopsis Spondyloarthritis (SpA) represents a group of interrelated diseases with common clinical features and a close association with HLA-B27. Figures on the incidence and prevalence of diseases vary highly dependent on methodological differences between studies, the case definition used to classify disease and on the prevalence of HLA-B27 in the population studied. When summarizing the available literature, incidence rates of SpA are mainly based on the ESSG criteria and range between 0.48 and 63/100.000 while prevalence rates vary between 0.01 and 2.5%. For ankylosing spondylitis (AS), the most widely recognized representative of the SpA group of diseases, incidence rates of 0.44-7.3/100.000 and prevalence rates of 0.007-1.7% have been described in studies that were based on the (modified) New York criteria to classify cases. The incidence of psoriatic arthritis (PsA) varied from 3.6 up to 23.1/100.000 in different studies and prevalence between <0.1% and 0.4%, using a variety of classification criteria. The incidence of ReA has been estimated between 0.6 up to 28/100.000 in studies based on different source populations and different case definitions. The newly proposed criteria for axial SpA and peripheral SpA present an attractive new approach to facilitate classification of the SpA into two main subtypes and the axial SpA criteria allow earlier detection of patents with inflammatory back pain. It should be emphasized that these criteria were developed for use in a (specialized) clinical setting and not for large epidemiological studies.

show abstract

“…In late May, the CMR prepared a table of specifications and a skills matrix, using the academic content of the Rheumatology course 13 and considering the estimated prevalence in our country 14 of rheumatic diseases. The final proposal included the design of 14 stations, with well-defined 7 requirements.…”

Section: Methodsmentioning

confidence: 99%

Performance of an Objective Structured Clinical Examination in a National Certification Process of Trainees in Rheumatology

Ramos¹,

Ramírez²,

Vallejo³

et al. 2015

Reumatología Clínica (English Edition)

View full text Add to dashboard Cite

Prevalence of Musculoskeletal Pain and Rheumatic Diseases in the Southeastern Region of Mexico. A COPCORD-Based Community Survey

Abstract: The prevalence of MSK pain was 19.6%. MSK pain was more prevalent in women and in the urban setting. A remarkably high prevalence of RA was found in this population, which suggests a role for geographic factors.

Cited by 60 publications

References 27 publications

The Epidemiology of Back Pain, Axial Spondyloarthritis and HLA-B27 in the United States

The Epidemiology of Back Pain, Axial Spondyloarthritis and HLA-B27 in the United States

Epidemiology of Spondyloarthritis

Performance of an Objective Structured Clinical Examination in a National Certification Process of Trainees in Rheumatology

Contact Info

Product

Resources

About